215 related articles for article (PubMed ID: 30497071)
1. Serum Bilirubin and Albumin in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Shu Y; Xu Y; Chen C; Li J; Li R; Wu H; Hu X; Lu Z; Yu X; Qiu W
Neuroimmunomodulation; 2018; 25(4):206-214. PubMed ID: 30497071
[TBL] [Abstract][Full Text] [Related]
2. Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Shu Y; Qin B; Xu Y; Sun X; Chen Z; Wang J; Peng L; Qiu W; Lu Z; Wu A
Neuroimmunomodulation; 2017; 24(4-5):256-263. PubMed ID: 29393234
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Wang Y; Lu T; Li R; Sun X; Li J; Chang Y; Hu X; Lu Z; Qiu W
Neurochem Int; 2017 Sep; 108():34-39. PubMed ID: 28192149
[TBL] [Abstract][Full Text] [Related]
4. Association of serum Gasdermin D with anti-N-methyl-D-aspartate receptor encephalitis.
Ma X; Chen C; Lu Y; Fang L; Cao B; Hu X; Qiu W; Shu Y
J Neurochem; 2021 Dec; 159(5):923-930. PubMed ID: 34418095
[TBL] [Abstract][Full Text] [Related]
5. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ma X; Yin Q; Zeng Z; Wang C; Yang Y; Guo S
Neuroimmunomodulation; 2018; 25(2):110-117. PubMed ID: 30157483
[TBL] [Abstract][Full Text] [Related]
6. Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
Shu Y; Chang Y; Wu H; Li J; Cao B; Sun X; Wang J; Peng L; Hu X; Yu X; Qiu W
Acta Neurol Scand; 2018 May; 137(5):515-522. PubMed ID: 29315460
[TBL] [Abstract][Full Text] [Related]
7. Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Chen C; Chen Y; Xu Y; Chang Y; Li R; Sun X; Peng L; Lu Z; Qiu W
Eur J Neurol; 2018 Jan; 25(1):178-184. PubMed ID: 29053906
[TBL] [Abstract][Full Text] [Related]
8. Elevated CHI3L1 and OPN levels in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Zhao J; Wang C; Zhang Y; Sun R; Wang H; Li G; Zhang J
J Neuroimmunol; 2019 Sep; 334():577005. PubMed ID: 31310926
[TBL] [Abstract][Full Text] [Related]
9. Low serum vitamin D levels and anti-N-methyl-d-aspartate receptor encephalitis: A case-control study.
Shu Y; Su Q; Liao S; Lu T; Li R; Sun X; Qiu W; Yang Y; Hu X; Lu Z
Neurochem Int; 2017 Jan; 102():89-94. PubMed ID: 27836631
[TBL] [Abstract][Full Text] [Related]
10. High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.
Wang N; Zeng Z; Wang B; Qin D; Wang T; Wang C; Guo S
Neurosci Lett; 2021 Feb; 746():135650. PubMed ID: 33485991
[TBL] [Abstract][Full Text] [Related]
11. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
12. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis-induced anti-N-methyl-d-aspartate receptor encephalitis: A hospital-based prospective study.
Ma J; Han W; Jiang L
Brain Dev; 2020 Feb; 42(2):179-184. PubMed ID: 31563418
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal brain morphology in anti-NMDA receptor encephalitis: a case report with controls.
Laurikainen H; Isotupa I; Nyman M; Ilonen T; Nummelin T; Salokangas RKR; Hietala J
BMC Psychiatry; 2019 May; 19(1):145. PubMed ID: 31077184
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.
Hara M; Martinez-Hernandez E; Ariño H; Armangué T; Spatola M; Petit-Pedrol M; Saiz A; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2018 Apr; 90(16):e1386-e1394. PubMed ID: 29549218
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
17. Late-onset anti-N-methyl-d-aspartate receptor encephalitis in China.
Zhang L; Liu X; Jiang XY; Wang YH; Li JM; Zhou D
Epilepsy Behav; 2018 Jul; 84():22-28. PubMed ID: 29734104
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
19. Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.
Liu CY; Zhu J; Zheng XY; Ma C; Wang X
Mediators Inflamm; 2017; 2017():6361479. PubMed ID: 28698711
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
